Brachytherapy: What's New and Where are We Going?
ฝัง
- เผยแพร่เมื่อ 25 ส.ค. 2022
- Peter J. Rossi, MD, discusses innovations and advances in low-dose-rate (LDR) and high-dose-rate (HDR) prostate brachytherapy as well as American Brachytherapy Society (ABS) initiatives and training opportunities. Dr. Rossi explains that innovations have resulted in brachytherapy treatment that is evidence-based, innovative, efficient, cost-effective, flexible, yields highly personalized treatment, and is of high value to multidisciplinary teams and to patients.
It appears HDR brachytherapy is becoming standard of care here in the big centers in NYC for local/regional prostate cancer radiation therapy as a boost to either IMRT or SBRT in GG 3, 4, and 5.
Are most brachytherapy procedures done with hormone therapy or other drugs ?